With reference to email L/SURV/ONL/PV/NP/2022-2023/2317 dated 22.04.2022, Zim Laboratories has informed that in its opinion, the Company has disclosed all the events, information that have a bearing on the operation/ performance of the company which include all price sensitive information, etc. that may have a bearing on the price behavior in the scrip. Further, the Company has made all the necessary disclosures pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Company shall continue to make applicable disclosures, within the stipulated time. The movement in the share price of the company is purely due to market conditions and absolutely market driven and, therefore, the Company is unable to comment on the movement in share price of the Company.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |